Abstract | BACKGROUND: METHODS: RESULTS:
Activin-B and follistatin mRNA levels were elevated in the human IPF lung. Immunoreactivity to activin-A, -B and follistatin localized predominantly to the hyperplastic, activated alveolar epithelium, but was also seen in inflammatory cells. Mice treated with sActRIIB-Fc showed increased skeletal muscle mass and a clear reduction in alveolar cell counts in bronchoalveolar lavage fluid, but no significant antifibrotic effect in the lung was observed. CONCLUSIONS:
|
Authors | Marjukka Myllärniemi, Jussi Tikkanen, Juha J Hulmi, Arja Pasternack, Eva Sutinen, Mikko Rönty, Outi Leppäranta, Hongqiang Ma, Olli Ritvos, Katri Koli |
Journal | BMC pulmonary medicine
(BMC Pulm Med)
Vol. 14
Pg. 170
(Nov 01 2014)
ISSN: 1471-2466 [Electronic] England |
PMID | 25361680
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Follistatin
- Inhbb protein, mouse
- RNA, Messenger
- Recombinant Fusion Proteins
- activin B
- inhibin beta A subunit
- sActRIIB-Fc fusion protein
- Activins
- Inhibin-beta Subunits
|
Topics |
- Activins
(drug effects, genetics, metabolism)
- Animals
- Bronchoalveolar Lavage Fluid
(cytology)
- Cell Count
- Disease Models, Animal
- Follistatin
(genetics, metabolism)
- Humans
- Immunity, Cellular
(drug effects)
- Inhibin-beta Subunits
(genetics)
- Male
- Mice
- Mice, Inbred C57BL
- Protein Biosynthesis
- Pulmonary Alveoli
(chemistry, immunology)
- Pulmonary Fibrosis
(metabolism)
- Quadriceps Muscle
(anatomy & histology, drug effects)
- RNA, Messenger
(metabolism)
- Recombinant Fusion Proteins
(pharmacology)
- Respiratory Mucosa
(chemistry, immunology)
- Signal Transduction
- Up-Regulation
(drug effects)
|